Ibnsina Pharma (ISPH) Financials
Annual financial statement highlights for Ibnsina Pharma covering fiscal years 2015–2025. Figures are updated weekly.
| Fiscal year | Revenue | Net income | EPS | Free cash flow | Total assets | Total debt | Dividend per share |
|---|---|---|---|---|---|---|---|
| 2025ended Dec 2025 | 76.6B | 951.98M | 0.77 | -805.66M | 36.21B | 26.67B | 0.26 |
| 2024ended Dec 2024 | 55.84B | 614.56M | 0.49 | -1.18B | 28.64B | 20.19B | 0.16 |
| 2023ended Dec 2023 | 33.95B | 213.66M | 0.17 | -228.23M | 18.55B | 13.13B | 0.00 |
| 2022ended Dec 2022 | 22.26B | 169.16M | 0.13 | -436.52M | 12.86B | 9.85B | 0.00 |
| 2021ended Dec 2021 | 21.73B | 314.73M | 0.26 | -487.96M | 11.28B | 7.98B | 0.10 |
| 2020ended Dec 2020 | 18.68B | 224.66M | 0.16 | 21.75M | 9.25B | 6.75B | 0.00 |
| 2019ended Dec 2019 | 16.6B | 318M | 0.27 | -417.07M | 8.17B | 5.47B | 0.05 |
| 2018ended Dec 2018 | 13.32B | 253.86M | 0.19 | -745.58M | 6.36B | 4.54B | 0.05 |
| 2017ended Dec 2017 | 9.59B | 170.14M | 0.16 | 239.79M | 4.33B | 3.29B | 0.00 |
| 2016ended Dec 2016 | 7.21B | 101.75M | 0.10 | 133.89M | 3.06B | 2.13B | — |
| 2015ended Dec 2015 | 5.33B | 57.36M | 0.06 | -11.28M | 2.21B | 1.61B | — |
All figures in EGP, as reported in the company’s annual results; updated weekly.